WCRX Warner Chilcott Plc - Ordinary Shares (MM)

Warner Chilcott plc (Nasdaq:WCRX) today announced that it will issue a press release detailing its second quarter 2013 financial results after the market close on Wednesday, July 24, 2013.

Although the Company will not be hosting a quarterly conference call, investors and other interested parties may access the press release by visiting http://ir.wcrx.com and clicking on Press Releases. 

The Company

Warner Chilcott is a leading specialty pharmaceutical company currently focused on the women's healthcare, gastroenterology, urology and dermatology segments of the branded pharmaceuticals market, primarily in North America.  We are a fully integrated company with internal resources dedicated to the development, manufacture and promotion of our products. WCRX-F

CONTACT: Rochelle Fuhrmann
         Senior Vice President, Finance
         973-442-3281
         rfuhrmann@wcrx.com
         
         Kevin Crissey
         Director, Investor Relations
         973-907-7084
         Kevin.Crissey@wcrx.com